BeyondSpring to Present at Two Upcoming Scientific Conferences in December
BeyondSpring to present at the 62nd American Society of Hematology (ASH) Annual Meeting and at the 2020 San Antonio Breast
Read moreAuthor: GlobeNewswire
Syneos Health Announces Closing of Offering of $600.0 Million of Senior Notes Due 2029
MORRISVILLE, N.C., Nov. 24, 2020 (GLOBE NEWSWIRE) — Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only
Read moreCodexis and Casdin Capital Launch SynBio Innovation Accelerator
Combines Codexis’ R&D and commercialization platform with Casdin Capital’s investment expertise to invest in and support innovative early stage life
Read moreCodexis and Casdin Capital Launch SynBio Innovation Accelerator
Combines Codexis’ R&D and commercialization platform with Casdin Capital’s investment expertise to invest in and support innovative early stage life
Read moreCodexis and Casdin Capital Launch SynBio Innovation Accelerator
Combines Codexis’ R&D and commercialization platform with Casdin Capital’s investment expertise to invest in and support innovative early stage life
Read moreCodexis and Casdin Capital Launch SynBio Innovation Accelerator
Combines Codexis’ R&D and commercialization platform with Casdin Capital’s investment expertise to invest in and support innovative early stage life
Read morePMV Pharmaceuticals to Present at Evercore ISI 3rd Annual HealthCONx Conference
CRANBURY, N.J., Nov. 24, 2020 (GLOBE NEWSWIRE) — PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery
Read morePMV Pharmaceuticals to Present at Evercore ISI 3rd Annual HealthCONx Conference
CRANBURY, N.J., Nov. 24, 2020 (GLOBE NEWSWIRE) — PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery
Read morePMV Pharmaceuticals to Present at Evercore ISI 3rd Annual HealthCONx Conference
CRANBURY, N.J., Nov. 24, 2020 (GLOBE NEWSWIRE) — PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery
Read morePMV Pharmaceuticals to Present at Evercore ISI 3rd Annual HealthCONx Conference
CRANBURY, N.J., Nov. 24, 2020 (GLOBE NEWSWIRE) — PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery
Read more